 | • レポートコード：QYR9ST04130 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん治療・バイオ治療の世界市場について調査・分析し、がん治療・バイオ治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、ホルモン療法、生物療法）、用途別（消費（販売）、家庭、病院）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん治療・バイオ治療市場動向 ・主要企業別マーケットシェア ・がん治療・バイオ治療の種類別市場規模2014-2019 （化学療法、放射線療法、ホルモン療法、生物療法） ・がん治療・バイオ治療の用途別市場規模2014-2019 （消費（販売）、家庭、病院） ・がん治療・バイオ治療の北米市場：主要企業・種類別/用途別市場規模 ・がん治療・バイオ治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん治療・バイオ治療の中国市場：主要企業・種類別/用途別市場規模 ・がん治療・バイオ治療の日本国内市場：主要企業・種類別/用途別市場規模 ・がん治療・バイオ治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん治療・バイオ治療のインド市場：主要企業・種類別/用途別市場規模 ・がん治療・バイオ治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb、AstraZeneca、Pfizer、Biogen IDEC、Sanofi、Genentech、Novartis、Johnson & Johnson、Roche and Schering-Plough） ・がん治療・バイオ治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the development of global cancer therapeutics and biotherapeutics market.
In 2018, the global Cancer Therapeutics And Biotherapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Therapeutics And Biotherapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Therapeutics And Biotherapeutics development in United States, Europe and China.
The key players covered in this study
Bristol-Myers Squibb
AstraZeneca
Pfizer
Biogen IDEC
Sanofi
Genentech
Novartis
Johnson & Johnson
Roche and Schering-Plough
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Market segment by Application, split into
Consumption (Sales)
Household
Hospital
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Therapeutics And Biotherapeutics status, future forecast, growth opportunity, key market and key players.
To present the Cancer Therapeutics And Biotherapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Therapeutics And Biotherapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Hormone Therapy
1.4.5 Biotherapy
1.5 Market by Application
1.5.1 Global Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2025)
1.5.2 Consumption (Sales)
1.5.3 Household
1.5.4 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Therapeutics And Biotherapeutics Market Size
2.2 Cancer Therapeutics And Biotherapeutics Growth Trends by Regions
2.2.1 Cancer Therapeutics And Biotherapeutics Market Size by Regions (2014-2025)
2.2.2 Cancer Therapeutics And Biotherapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Therapeutics And Biotherapeutics Market Size by Manufacturers
3.1.1 Global Cancer Therapeutics And Biotherapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Therapeutics And Biotherapeutics Key Players Head office and Area Served
3.3 Key Players Cancer Therapeutics And Biotherapeutics Product/Solution/Service
3.4 Date of Enter into Cancer Therapeutics And Biotherapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019)
4.2 Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
5.2 Cancer Therapeutics And Biotherapeutics Key Players in United States
5.3 United States Cancer Therapeutics And Biotherapeutics Market Size by Type
5.4 United States Cancer Therapeutics And Biotherapeutics Market Size by Application
6 Europe
6.1 Europe Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
6.2 Cancer Therapeutics And Biotherapeutics Key Players in Europe
6.3 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type
6.4 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application
7 China
7.1 China Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
7.2 Cancer Therapeutics And Biotherapeutics Key Players in China
7.3 China Cancer Therapeutics And Biotherapeutics Market Size by Type
7.4 China Cancer Therapeutics And Biotherapeutics Market Size by Application
8 Japan
8.1 Japan Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
8.2 Cancer Therapeutics And Biotherapeutics Key Players in Japan
8.3 Japan Cancer Therapeutics And Biotherapeutics Market Size by Type
8.4 Japan Cancer Therapeutics And Biotherapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
9.2 Cancer Therapeutics And Biotherapeutics Key Players in Southeast Asia
9.3 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Type
9.4 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Application
10 India
10.1 India Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
10.2 Cancer Therapeutics And Biotherapeutics Key Players in India
10.3 India Cancer Therapeutics And Biotherapeutics Market Size by Type
10.4 India Cancer Therapeutics And Biotherapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Therapeutics And Biotherapeutics Market Size (2014-2019)
11.2 Cancer Therapeutics And Biotherapeutics Key Players in Central & South America
11.3 Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Type
11.4 Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Therapeutics And Biotherapeutics Introduction
12.1.4 Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Therapeutics And Biotherapeutics Introduction
12.2.4 AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Therapeutics And Biotherapeutics Introduction
12.3.4 Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Biogen IDEC
12.4.1 Biogen IDEC Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Therapeutics And Biotherapeutics Introduction
12.4.4 Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.4.5 Biogen IDEC Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Therapeutics And Biotherapeutics Introduction
12.5.4 Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Genentech
12.6.1 Genentech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Therapeutics And Biotherapeutics Introduction
12.6.4 Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.6.5 Genentech Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Therapeutics And Biotherapeutics Introduction
12.7.4 Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Therapeutics And Biotherapeutics Introduction
12.8.4 Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Roche and Schering-Plough
12.9.1 Roche and Schering-Plough Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Therapeutics And Biotherapeutics Introduction
12.9.4 Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
12.9.5 Roche and Schering-Plough Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Therapeutics And Biotherapeutics Key Market Segments
Table Key Players Cancer Therapeutics And Biotherapeutics Covered
Table Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Figure Biotherapy Figures
Table Key Players of Biotherapy
Table Global Cancer Therapeutics And Biotherapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Consumption (Sales) Case Studies
Figure Household Case Studies
Figure Hospital Case Studies
Figure Cancer Therapeutics And Biotherapeutics Report Years Considered
Table Global Cancer Therapeutics And Biotherapeutics Market Size 2014-2025 (Million US$)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Therapeutics And Biotherapeutics Market Share by Regions 2014-2019
Figure Global Cancer Therapeutics And Biotherapeutics Market Share by Regions 2014-2019
Figure Global Cancer Therapeutics And Biotherapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Therapeutics And Biotherapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Therapeutics And Biotherapeutics Market Share by Manufacturers (2014-2019)
Figure Global Cancer Therapeutics And Biotherapeutics Market Share by Manufacturers in 2018
Table Global Cancer Therapeutics And Biotherapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Therapeutics And Biotherapeutics Product/Solution/Service
Table Date of Enter into Cancer Therapeutics And Biotherapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Therapeutics And Biotherapeutics Market Size Share by Type (2014-2019)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size Market Share by Type (2014-2019)
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Therapeutics And Biotherapeutics Market Size Share by Application (2014-2019)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size Market Share by Application (2014-2019)
Figure Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Application in 2018
Figure United States Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table United States Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table United States Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Figure Europe Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Figure China Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table China Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-20189) (Million US$)
Table China Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table China Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table China Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Figure Japan Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table Japan Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table Japan Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Figure India Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table India Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table India Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table India Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table India Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Figure Central & South America Cancer Therapeutics And Biotherapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Therapeutics And Biotherapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Therapeutics And Biotherapeutics Market Share (2018-2019)
Table Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Therapeutics And Biotherapeutics Market Share by Type (2014-2019)
Table Central & South America Cancer Therapeutics And Biotherapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Therapeutics And Biotherapeutics Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Biogen IDEC Company Details
Table Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Biogen IDEC Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Biogen IDEC Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Genentech Company Details
Table Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Genentech Recent Development
Table Novartis Company Details
Table Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Novartis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Roche and Schering-Plough Company Details
Table Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2014-2019)(Million US$)
Figure Roche and Schering-Plough Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2014-2019)
Table Roche and Schering-Plough Recent Development
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Therapeutics And Biotherapeutics Market Size Share by Regions (2019-2025)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size Share by Regions in 2025
Figure United States Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Therapeutics And Biotherapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size by Product (2019-2025)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size by Product in 2025
Table Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size by Application (2019-2025)
Figure Global Cancer Therapeutics And Biotherapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- ホルモン不応性前立腺癌(HRPCA)の世界市場：市場規模・現状・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 皮膚がん治療薬の世界市場：市場規模・現状・予測 On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…
- 皮膚がん治療薬の世界市場：市場規模・現状・予測 On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…
- がん遺伝子治療の世界市場：市場規模・現状・予測 Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…